Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Free Report) have been given a consensus rating of “Hold” by the five research firms that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $8.00.
Several analysts have commented on the company. Benchmark cut Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Monday, August 7th. StockNews.com assumed coverage on Tabula Rasa HealthCare in a report on Saturday. They set a “hold” rating for the company. SVB Securities upgraded Tabula Rasa HealthCare from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $7.00 to $10.00 in a report on Wednesday, May 10th. William Blair cut Tabula Rasa HealthCare from an “outperform” rating to a “market perform” rating in a report on Monday, August 7th. Finally, SVB Leerink upgraded Tabula Rasa HealthCare from a “market perform” rating to an “outperform” rating in a report on Wednesday, May 10th.
Hedge Funds Weigh In On Tabula Rasa HealthCare
Tabula Rasa HealthCare Stock Down 0.1 %
NASDAQ:TRHC opened at $10.26 on Friday. The company has a market capitalization of $277.58 million, a PE ratio of -2.66 and a beta of 1.71. Tabula Rasa HealthCare has a 52-week low of $3.15 and a 52-week high of $10.37. The stock has a fifty day simple moving average of $8.97 and a 200-day simple moving average of $6.93.
Tabula Rasa HealthCare (NASDAQ:TRHC – Get Free Report) last posted its quarterly earnings data on Monday, August 7th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.24. The company had revenue of $90.04 million for the quarter, compared to analysts’ expectations of $88.82 million. As a group, equities analysts anticipate that Tabula Rasa HealthCare will post -0.91 earnings per share for the current year.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention.
- Five stocks we like better than Tabula Rasa HealthCare
- What is a Secondary Public Offering? What Investors Need to Know
- MarketBeat Week in Review – 8/28 – 9/1
- 3 Monster Growth Stocks to Buy Now
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- Are Penny Stocks a Good Fit for Your Portfolio?
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.